COVID-19 vaccines generated trillions in benefits, far exceeding their estimated costs
Every dollar spent on COVID-19 vaccine development and distribution generated an estimated $81 to $810 in economic value during the first year that vaccines were given, according to new research published in the journal PLOS Medicine.
Research published in PLOS Medicine reveals that the COVID-19 vaccines generated trillions in health and economic benefits during their first year of availability, far surpassing the $79.4 billion invested in their development and distribution. The study, which analyzed data from 173 countries, found that each dollar spent on vaccines yielded $81 to $810 in value.
This return on investment accounted for health improvements, including years of life gained and quality of life, as well as economic gains from reduced hospitalizations and productivity losses. While high-income nations reaped the greatest benefits due to earlier access and higher vaccination rates, low- and middle-income countries still experienced substantial savings in healthcare and productivity costs despite limited vaccine availability.
The findings underscore the critical importance of equitable vaccine distribution to maximize the global health and economic impact of COVID-19 vaccines.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
